NCT06196489 · Veterans Medical Research Foundation
Adapting an Intervention for Vaping in Young Veterans
What this study is about
The objective of this proposal is to adapt an evidence-based combustible tobacco counseling intervention following an evidence-based process to include e-cigarette use and update its components for emerging adults (EA). 1. Examine factors related to e-cigarette use, barriers to cessation, and facilitators of use of cessation services among an EA population. 2.
View original scientific description
The objective of this proposal is to adapt an evidence-based combustible tobacco counseling intervention following an evidence-based process to include e-cigarette use and update its components for emerging adults (EA). 1. Examine factors related to e-cigarette use, barriers to cessation, and facilitators of use of cessation services among an EA population. 2. Beta-test an initial version of the intervention, delivered via video telehealth and telephone, to examine usability and acceptability.
Interventions
BEHAVIORAL
adapted vaping cessation intervention
Behavioral intervention for vaping cessation
Primary outcome measures
e-cigarette use frequency
Time frame: end of treatment (8 weeks post-baseline) and 30 days thereafter
number of days using e-cigarettes in the past 7 days at the time of assessment
e-cigarette use quantity
Time frame: end of treatment (8 weeks post-baseline) and 30 days thereafter
number of e-cigarette uses per day
Client Satisfaction Questionnaire (CSQ-8)
Time frame: end of treatment (8 weeks post-baseline) and 30 days thereafter
Participant satisfaction ratings; higher scores indicate greater satisfaction with the intervention
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- daily e-cigarette user for at least the past 6 months
- 18-30 years old
- willing to enroll in a program to quit nicotine use within 30 days
- owns smartphone or computer/tablet with camera and internet connectivity
- English speaker
Exclusion criteria
- ICD-10 diagnosis of dementia
- current use of combustible tobacco products at least weekly
Where
- San Diego, California
Collaborators
University of California
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jan 8, 2026 · Source of record for eligibility and locations